Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 596

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 596
---
 | Book Value |     |           |
|:-----------------|:----|:-----------|:----|:-----------|:----|:---------|:----|:---------|:----|------------:|:----|-----------:|:----|----------:|
| Heritas Ltd.(*)  |     | 01/6/2022  |     | 1/6/2028   |     | 6.5%     |     | US$      |     |     604,538 |     |    642,699 |     |   303,500 |
| CIBIC            |     | 01/17/2023 |     | 01/17/2028 |     | 6.5%     |     | US$      |     |     979,496 |     |  1,032,078 |     |   264,649 |
| CIBIC            |     | 10/1/2023  |     | 10/1/2028  |     | 6.5%     |     | US$      |     |     238,743 |     |    247,919 |     |         — |
| BIOCERES         |     | 01/17/2023 |     | 01/17/2028 |     | 6.5%     |     | US$      |     |     552,935 |     |    597,846 |     |   561,808 |
| BIOCERES         |     | 09/1/2023  |     | 9/1/2028   |     | 6.5%     |     | US$      |     |     135,025 |     |    140,466 |     |         — |
| Total Borrowings |     |            |     |            |     |          |     |          |     |   2,510,737 |     |  2,661,008 |     | 1,129,957 |

____________ (*)See Note 1 about the restructuring of intercompany debt with Heritas Ltd. as an element of the BCA.

F-98

Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 20.Related parties (cont.) Outstanding balances and transactions with other related parties: CIBIC The Group commercializes its diagnostics services through an exclusive